Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Minerva Neurosciences, Inc. (NERV)

Minerva Neurosciences names Controller Anthony Aliquo chief accounting officer

Neutral Impact 2 of 5 leadership Written later

Minerva Neurosciences' board appointed Anthony Aliquo, its Vice President and Controller, as chief accounting officer and principal accounting officer effective August 10, 2026. CFO Fred Ahlholm stepped back from the principal accounting officer role but remains chief financial officer and principal financial officer. The change is an internal reassignment of accounting oversight, with a salary increase and higher bonus target for Aliquo.

Key points

  • Anthony Aliquo, age 39, appointed chief accounting officer effective August 10, 2026
  • Fred Ahlholm continues as Chief Financial Officer and principal financial officer
  • Aliquo's base salary increased to $296,696, effective July 1, 2026
  • Aliquo's annual performance bonus target raised to 35% of base salary

The filing

CompanyMinerva Neurosciences, Inc. (NERV)
Form8-K, current report
Filed with the SECAug 12, 2026, 4:05 PM ET
Accession number0001193125-26-346817

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:38 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 12, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.